Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Acumen Pharmaceuticals, Inc./ 4

SEC Filing · 4

Acumen Pharmaceuticals, Inc.

ABOSNASDAQEQUITYCurrent

SEC Filing

Filed Jun 5, 2026Accepted Jun 5, 2026, 4:30 PM EDTCIK 1576885Accession 0001628280-26-041273
View company →Permanent SEC source ↗
Share

Company context

Current securities

ABOSNASDAQ · EQUITY · Current

Recent company filings

  1. Regulation FD DisclosureSep 16, 2026
  2. S-8 filingAug 12, 2026
  3. 10-Q filingAug 12, 2026
  4. Results of Operations and Financial Condition · Regulation FD DisclosureAug 12, 2026
  5. Regulation FD Disclosure · Other EventsJun 16, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗